logo
  

AXA Q1 Revenues Down 3%

AXA (AXAHY.PK) Tuesday reported its first-quarter total gross revenues of 30.7 billion euros, down 3% from 31.7 billion euros last year.

On comparable basis, revenues rose 2% year-over-year.

"AXA's total revenues grew by 2% in the first quarter, in a context which continued to be marked by Covid#19 related restrictions", said Etienne Bouas- aurent, Group Chief Financial Officer. "This good performance was underpinned by sustained growth in our preferred segments, notably with P&C Commercial lines up 4%, Health up 5%, and with continued positive flowsand a favorable mix in L&S."

Property & Casualty segment revenues dropped 4% to 17.4 billion euros, while Health segment revenues gained 3% to 4.2 billion euros. Life % Savings slipped 4% to 8.6 billion euros, while Asset Management gained 16% to 0.4 billion euros.

"AXA XL performed well in the quarter, pursuing its underwriting discipline, achieving significant price increases, targeted exposure reductions, and growing revenues by 4%. AXA Investment Managers also delivered strong performance, with Euro 13 billion net inflows and revenues up 17%."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings.
RELATED NEWS
Follow RTT